After Tragedy, an Entrepreneur’s Triumph
Brian Gormley of the Wall Street Journal publishes article on Lungpacer’s 15-year journey from a deeply personal mission sparked by a family tragedy to groundbreaking medical innovation. Nearly 2.5 million patients in the U.S. require mechanical ventilation each year, and for many, weaning off ventilation can be a struggle. Sadly, some never do. Research shows […]
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System’s Breakthrough Results in Ventilator Weaning
International multi-center trial demonstrates AeroPace strengthens the diaphragm by 50%, weans more patients from ventilation, and reduces ventilator time by 3 days in patients difficult to wean from mechanical ventilation EXTON, PA, June 12, 2025 – Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the […]
Lungpacer announces 150th global patent for interventional neurostimulation technology portfolio
This 150th patent is a testament to our team’s ingenuity and dedication to serving the approximately 2.5 million US patients who require mechanical ventilation every year and our commitment to revolutionizing mechanical ventilation, creating a future where every patient can breathe easier and recover faster. With thanks to Viral Thakkar Kaitlin Taylor Matt Gani Gautam […]
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
Exton, PA – April 28, 2025 – This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill patients from mechanical ventilation and may help improve lung, heart, and brain health in ventilated patients. ISHLT 2025, Boston, April […]
April 2025 | Cardiovascular Research Foundation THT | Diaphragm Neurostimulation to optimize Biventricular Performance during Invasive Mechanical Ventilation for Acute Respiratory Failure
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience Exton, PA – March 24, 2025 – Lungpacer Medical today announced the appointment of Kevin Kearney as chief commercial officer (CCO). Kearney brings over 20 years of commercial leadership, business development, and strategic sales operations experience in the medical device and healthcare […]
Lungpacer announces participation and presentation at the LSI USA 2024 Conference
From LSI: “Lungpacer Medical (hashtag#LSIUSA24 Innovator) has designed the AeroPace® System to stimulate the nerves that activate the diaphragm muscle to rebuild diaphragm strength and shorten the time on mechanical ventilation for critical care patients. Over a third of ventilated patients in ICUs require more than 4 days of mechanical ventilation. Studies have shown that […]